In a separate study, mutations in angiogenesis-related genes were identified in 38% (15/39) of angiosarcoma tumour samples [28], including recurrent mutations in vascular endothelial-phosphotyrosine phosphatase (VE-PTP) and phospholipase gamma 1 (PLCG1). Here, PLCG1 is linked to angiosarcoma.